B+
Bull case
25%
Probability
Target price
$67.00
+34.2% vs current
SION
Sionna TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-04
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+1Most likely
B
Base case
45%
Probability
Target price
$48.00
-3.9% vs current
B-
Bear case
30%
Probability
Target price
$30.00
-39.9% vs current
AI sentiment snapshot
Latest data as of 2026-08-04
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+51.3
Score
AI commentary
The packet contains no recent news or social coverage. The August 3 earnings trigger appears to be a scheduled follow-up rather than confirmed evidence of a new print; earnings surprise, revisions, target changes, and attributable market reaction remain unavailable. Treat the stock as a low-buzz, event-driven monitoring situation.
RankAlpha Sentiment Codex - 2026-08-04
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-11-02eventSION-719 Phase 2a topline readoutHigh impact
Enrollment was completed in the PreciSION CF Phase 2a proof-of-concept trial, with topline data anticipated in summer 2026. The readout is the principal near-term value inflection, but no results or exact release date are confirmed. [#SEC-8K-2026-05-12]
2026-11-02eventSION-451 dual-combination Phase 1 readoutHigh impact
The ongoing Phase 1 trial of SION-451 with SION-2222 and SION-109 was described as on track for summer 2026 topline data. Evidence remains early-stage and limited to healthy-volunteer development. [#PR-EARNINGS-2026-05-12]
2026-11-02catalystRepeated insider-sale overhangMedium impact
SEC Form 4 filings show open-market sales by director-linked holders on June 30 and July 7, plus an officer sale. This supports a sentiment overhang only and is not evidence of operating deterioration. [#SEC-FORM4-2026-07-02] [#SEC-FORM4-2026-07-09]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-04 • Updated nightlySource: Internal modelMethodology